Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V36946 | (Nle8·18,Tyr34)-pTH (1-34) amide (bovine) | 64763-77-5 | (Nle8·18,Tyr34)-pTH (1-34) amide (bovine) is a peptide compound. | |
V36963 | (Nle8·18,Tyr34)-pTH (3-34) amide (bovine) | 64297-16-1 | (Nle8·18,Tyr34)-pTH (3-34) amide (bovine) is a peptide compound. | |
V36964 | (Nle8·18,Tyr34)-pTH (7-34) amide (bovine) | 71539-01-0 | (Nle8·18,Tyr34)-pTH (7-34) amide (bovine) is a peptide compound. | |
V36953 | (Nle8·21,Tyr34)-pTH (1-34) amide (rat) | 105267-88-7 | (Nle8·21,Tyr34)-pTH (1-34) amide (rat) is a peptide compound. | |
V34894 | (p-Amino-Phe6)-Angiotensin II | 90937-05-6 | (p-Amino-Phe6)-Angiotensin II is a peptide compound. | |
V37025 | (p-Bz-Phe8)-Substance P | (p-Bz-Phe8)-Substance P is a peptide compound. | ||
V37073 | (p-Chloro-D-Phe6,Leu17)-VIP (human, bovine, porcine, rat)|[4ClDPhe6,Leu17] VIP | 102805-45-8 | [Dp-Cl-Phe6,Leu17]-VIP is a competitive and selective vasoactive intestinal peptide (VIP) receptor blocker (antagonist) with IC50 of 125.8 nM. | |
V34881 | (Pen5)-Urotensin II (4-11) (human) | 473902-31-7 | (Pen5)-Urotensin II (4-11) (human) is a peptide compound. | |
V34924 | (Phe(4-Cl)5·8)-Bradykinin | 125229-63-2 | (Phe(4-Cl)5·8)-Bradykinin is a peptide compound. | |
V37055 | (Phe1,Ser2)-TRAP-6 | 374898-11-0 | (Phe1,Ser2)-TRAP-6 is a peptide compound. | |
V36606 | (Phe1-(R)-Gly2)-Nociceptin (1-13) amide | (Phe1-(R)-Gly2)-Nociceptin (1-13) amide is a peptide compound. | ||
V36565 | (Phe13,Tyr19)-MCH (human, mouse, rat) | 160201-86-5 | (Phe13,Tyr19)-MCH (human, mouse, rat) is a potent ligand for SLC-1 and S643b receptors. | |
V36821 | (Phe2)-TRH | 34783-35-2 | [Phe2]-TRH is a thyrotropin-releasing hormone analog with conformational similarity to Leu5-enkephalin. | |
V36898 | (Phe2,Orn8)-Oxytocin | 2480-41-3 | (Phe2,Orn8)-Oxytocin is a selective V1 vasopressin agonist. | |
V36736 | (Phe22)-Big Endothelin-1 fragment (19-37) (human) | 189064-07-1 | (Phe22)-Big Endothelin-1 fragment (19-37) (human) is a peptide compound. | |
V36702 | (Phe4)-Dermorphin (1-4) amide | 118476-87-2 | (Phe4)-Dermorphin (1-4) amide is a peptide compound. | |
V36721 | (Phe7)-Dynorphin A (1-7) | (Phe7)-Dynorphin A (1-7) is a peptide compound. | ||
V36708 | (Phe7)-Dynorphin A (1-7) amide | (Phe7)-Dynorphin A (1-7) amide is a peptide compound. | ||
V35073 | (Phenylac-Tyr1,D-Arg2,Phe(4-Cl)6,Homoarg9,Tyr(Me)10,Abu15,Nle27,D-Arg28,Homoarg29)-GRF (1-29) amide (human) | 221377-79-3 | JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. | |
V36810 | (Phenylac-Tyr1,D-Arg2,Phe(4-Cl)6,Homoarg9,Tyr(Me)10,Abu15,Nle27,D-Arg28,Homoarg29)-GRF (1-29) amide (human) | 221377-79-3 | JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. |